Your session is about to expire
← Back to Search
End-of-Life Planning for Cancer
Study Summary
This trial will study how best to support people with terminal cancer and their loved ones as they make end-of-life plans.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Post-Mortem Plan
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the scope of involvement in this clinical experiment?
"Affirmative. Clinicaltrials.gov data confirms that the trial, which was unveiled on September 17th 2021, is currently recruiting participants. Approximately 300 individuals from 1 medical centre are required for this study."
Is the subject pool of this clinical trial limited to those over 30 years old?
"This medical trial is recruiting participants aged 18 to 100. Additionally, there are 46 separate studies for minors and 706 distinct trials targeting elderly patients."
What criteria must a person satisfy in order to qualify for enrollment in this clinical trial?
"This clinical trial is recruiting up to 300 individuals, aged 18-100 years old with metastatic cancer."
Are there any open spots left in this clinical experiment?
"Affirmative. According to the information on clinicaltrials.gov, this research is currently searching for volunteers and was originally posted on September 17th 2021, with its most recent update being February 2nd 2022. The experiment necessitates 300 subjects enrolled at a single location."
Share this study with friends
Copy Link
Messenger